Tarabih Moataz, Ovdat Tal, Karkabi Basheer, Barel Maguli S, Muhamad Mahamid, Beigel Roy, Orvin Katia, Shiran Avinoam, Eitan Amnon
Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel.
The Israeli Center for Cardiovascular Research, Sheba Medical Center, Tel Aviv, Israel.
Int J Cardiol Heart Vasc. 2024 Jul 27;53:101476. doi: 10.1016/j.ijcha.2024.101476. eCollection 2024 Aug.
Patients with ST-elevation myocardial infarction (STEMI) and late arrival (>12 h) after symptom onset, are at high risk for mortality and heart failure and represent a challenge for management. We aimed to define patient characteristics, management, and outcome of late-arrival STEMI in Israel over the last 20 years.
We analyzed data of late-arrival STEMI (12-48 h and > 48 h) from the biennial acute coronary syndrome Israeli Surveys (ACSIS), as well as time-dependent changes [early (2000-2010) Vs. late (2013-2021) period].
Data regarding time from symptom onset to hospital arrival was available in 6,466 STEMI patients. Of these, 9.6 % arrived 12-48 h and 3 % >48 h from symptom onset. Late-arrival patients were more likely to be older women with diabetes and high GRACE score and less likely to have prior myocardial infarction.In recent years, 95 % of patients arriving 12-48 h and 96 % of those arriving > 48 h had coronary angiography, as opposed to 75 % and 77 % in the early years (p = 0.007). Percutaneous coronary intervention (PCI) increased from 60 % and 55 % respectively to 85 % (p ≤ 0.001).TIMI-3 flow after primary PCI was 89-92 %, irrespective of arrival time. Late arrival patients (12-48 h but not > 48 h) who had PCI had better adjusted 1-year survival, HR 0.49 (95 %CI 0.29-0.82), p = 0.01.
Late-arrival STEMI patients have higher risk characteristics. Most late-arrival patients undergo coronary angiography and PCI and have TIMI-3 flow after primary PCI. In patients arriving 12-48 h after symptom onset PCI is associated with better survival.
ST段抬高型心肌梗死(STEMI)患者且症状发作后延迟就诊(>12小时),死亡率和心力衰竭风险较高,对治疗构成挑战。我们旨在确定过去20年以色列延迟就诊STEMI患者的特征、治疗及预后情况。
我们分析了来自以色列两年一次急性冠状动脉综合征调查(ACSIS)中延迟就诊STEMI(12 - 48小时及>48小时)的数据,以及时间依赖性变化[早期(2000 - 2010年)与晚期(2013 - 2021年)]。
6466例STEMI患者有症状发作至入院时间的数据。其中,9.6%在症状发作后12 - 48小时就诊,3%在>48小时就诊。延迟就诊患者更可能是患有糖尿病且GRACE评分高的老年女性,既往有心肌梗死的可能性较小。近年来,12 - 48小时就诊的患者中95%、>48小时就诊的患者中96%接受了冠状动脉造影,而早期分别为75%和77%(p = 0.007)。经皮冠状动脉介入治疗(PCI)分别从60%和55%增至85%(p≤0.001)。直接PCI术后TIMI - 3级血流为89% - 92%,与就诊时间无关。接受PCI的延迟就诊患者(12 - 48小时而非>48小时)调整后的1年生存率较好,HR为0.49(95%CI 0.29 - 0.82),p = 0.01。
延迟就诊的STEMI患者具有更高的风险特征。大多数延迟就诊患者接受了冠状动脉造影和PCI,直接PCI术后有TIMI - 3级血流。症状发作后12 - 48小时就诊的患者接受PCI与更好的生存率相关。